位置：成果数据库 > 期刊 > 期刊详情页
A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falcipa
  • 时间：0
  • 相关项目：PfCP-2.9疟疾疫苗免疫保护作用机制的研究
同期刊论文项目
PfCP-2.9疟疾疫苗免疫保护作用机制的研究
期刊论文 14 会议论文 2 著作 1
同项目期刊论文
Construction and evaluation of a multistage combination　vaccine against malaria
Evaluation of three Pichia-expressed Plasmodium falciparum merozoite proteins as a combination vacci
Preclinical evaluation of a chimeric malaria vaccine candidate in Montanide ISA 720: immunogenicity
No miRNA were found in Plasmodium and the ones identified in　erythrocytes could not be correlated wi
A Novel DBL-Domain of the P. falciparum332 Molecule　Possibly Involved in Erythrocyte Adhesion，
恶性虐原虫融合抗原PfCP-2的单克隆抗体制备及功能研究
恶性疟原虫裂殖子表面蛋白1 EGF2结构域的表达及免疫反应特点
伯氏疟原虫红内期融合抗原的构建、表达及其免疫原性研究
恶性疟原虫裂殖子表面蛋白3功能区片段的制备及其免疫原性分析
Changing the N-terminal sequence protects recombinant Plasmodium falciparum circumsporozoite protein
Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1 /MSP-1 Chimeric Protein
Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits.
恶性疟原虫融合抗原PfCP-2．9的单克隆抗体制备及功能分析